Back to Search

A Randomized, Blinded, Placebo-controlled, Phase 2 Study of INBRX-109 in Unresectable or Metastatic Conventional Chondrosarcoma


  • Protocol Number: 202112016
  • Principal Investigator: Van Tine, Brian
  • Cancer Types: Sarcoma

For more information on this trial, contact us here:

Phone
800-600-3606
Email
[email protected]

Brief Summary

Protocol Interventions